These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25494645)
1. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645 [TBL] [Abstract][Full Text] [Related]
2. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Sepulveda VA; Weigel NL; Falzon M Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370 [TBL] [Abstract][Full Text] [Related]
5. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237 [TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697 [TBL] [Abstract][Full Text] [Related]
7. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Thorne JL; Maguire O; Doig CL; Battaglia S; Fehr L; Sucheston LE; Heinaniemi M; O'Neill LP; McCabe CJ; Turner BM; Carlberg C; Campbell MJ Nucleic Acids Res; 2011 Mar; 39(6):2045-56. PubMed ID: 21088000 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes. Seuter S; Pehkonen P; Heikkinen S; Carlberg C Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200 [TBL] [Abstract][Full Text] [Related]
10. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193 [TBL] [Abstract][Full Text] [Related]
11. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Wang WL; Chatterjee N; Chittur SV; Welsh J; Tenniswood MP Mol Cancer; 2011 May; 10():58. PubMed ID: 21592394 [TBL] [Abstract][Full Text] [Related]
12. African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Siddappa M; Hussain S; Wani SA; White J; Tang H; Gray JS; Jafari H; Wu HC; Long MD; Elhussin I; Karanam B; Wang H; Morgan R; Hardiman G; Adelani IB; Rotimi SO; Murphy AR; Nonn L; Davis MB; Kittles RA; Hughes Halbert C; Sucheston-Campbell LE; Yates C; Campbell MJ Cancer Res Commun; 2023 Apr; 3(4):621-639. PubMed ID: 37082578 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
14. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
15. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model. Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352 [TBL] [Abstract][Full Text] [Related]
16. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728 [TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells. Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609 [TBL] [Abstract][Full Text] [Related]
19. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development. Luo W; Liu L; Yang L; Dong Y; Liu T; Wei X; Liu D; Gu H; Kong J; Yuan Z; Zhao Q Metabolism; 2018 Aug; 85():139-150. PubMed ID: 29604361 [TBL] [Abstract][Full Text] [Related]
20. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]